[Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D001799:Blood Sedimentation; D002097:C-Reactive Protein; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009088:Mucoproteins / Q000032:analysis; D011033:Podophyllin / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D009088:Mucoproteins; D006046:Gold; D003520:Cyclophosphamide; D011033:Podophyllin; D002097:C-Reactive Protein; D001241:Aspirin
Ergebnisse der klinischen Behandlung von Kranken mit sehr aktiver rheumatoider Arthritis. Vergleichende Darstellung der Therapie mit nicht-steroiden Antiphlogistica, Goldsalzen (Sodium aurothiosulfat) und den immunosuppressiven Medikamenten Proresid und Endoxan.